Foresee Pharmaceuticals (TPEx: 6576) announced that its oral ALDH2 activator, mirivadelgat, has been selected for clinical testing in Parkinson's disease ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE